Physician profile
Dane L Maxfield
NPI 1992794986
$489.14
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.30 · 2020: $75.44 · 2021: $83.18 · 2022: $104 · 2023: $74.40 · 2024: $64.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.03 | 2019-2023 | |
| Abbott Laboratories | $57.35 | 2023-2024 | Freestyle Libre 3, Proclaim |
| Boston Scientific Corporation | $53.52 | 2019-2023 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $47.16 | 2021-2022 | |
| Glaxosmithkline, LLC. | $39.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $35.19 | 2022 | |
| Pharming Healthcare, INC. | $33.37 | 2020-2022 | |
| Allergan, INC. | $19.50 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $16.91 | 2020 | |
| Dexcom, INC. | $16.44 | 2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $13.73 | 2024 | |
| Janssen Biotech, INC. | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Maxfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.